Besins Healthcare pharmaceutical plant has been completed in Novoselki Industrial Park, Yaroslavl.
The company is to produce micronized progesterone, a female hormone equivalent. The drug has been widely used in obstetrics and gynaecology and is included in the essential medicines list.
Japanese pharmaceutical company Takeda invested over 98 million euros in the production of pharmaceuticals in Russia, 477 million rubles of which were assigned to the production of innovation orphan drug Ixazomib named Ninlaro for patients with multiple myeloma (blood cancer). This information was provided to TASS by a company’s press service representative at the opening ceremony of the drug manufacturing site of the plant in Yaroslavl.
Construction of 450 MW Huadian-Teninskaya CCPP has been completed in Yaroslavl Region Pre-commissioning works have been started at the facility that is expected to reduce the region’s power shortages
Besins Healthcare pharmaceutical company has been completed in the Industrial Park Novoselki.The company will produce the micronized progesterone, which is a full analogues of a feminine hormone. The drug has been widely used in the sphere of Obstetrics and Gynaecology and is included in the list of vital medicines.
UEC-Saturn (member of the United Engine Corporation, UEC) and the French Safran Aircraft Engines (member of the Safran Group) concluded a master agreement for development of a modification of the SaM146 engine for remotorization of the Russian amphibian aircraft Be-200. The news was reported by the press-office of UEC.
Besins Healthcare SA will build a new drug manufacturing plant in Yaroslavl Region. The new facility will produce Utrogestan which is included in the Russia's Essential Drugs List. Project investment will account for RUB 500 mln, the launch of commercial production is scheduled for 2019.